Insider Trading Intelligence

…

FREE · DAILY · 6 AM ET

The morning brief, before the bell.

One short email. Insider buys, congressional trades, and plain-English analysis.

Track what insiders are doing with their own money.

Product

Insider trades Congress trades Financials Stock screener Pricing

Data

SEC EDGAR House.gov Senate.gov Methodology Data Status

Company

About Blog Terms Privacy

© 2026 MarketPeel, Inc.NOT INVESTMENT ADVICE · DATA VIA SEC EDGAR

Home
Stocks
Health Care
Allogene Therapeutics, Inc. (ALLO)

Allogene Therapeutics, Inc.

ALLO

NASDAQHealth Care

Biotechnology · SOUTH SAN FRANCISCO, CA, United States

$2.12

+0.47% (+$0.01)2026-07-08

Smart-Money SignalNeutral · 46/100— Insiders are net sellers over 90 days (-$22K, 2 sales vs 5 buys)

Revenue$0

Net Income-$42.6M

EPS$-0.18

Market Cap$519.0M

Price Performance

Historical data including institutional events

Company Profile

D

David Chang

CEO & Executive Director

Company profile for Allogene Therapeutics, Inc. (ALLO) stock, with a description, list of executives, contact details and other key facts.

Founded: 2017
Employees: 1
Headquarters: SOUTH SAN FRANCISCO, CA, United States
Website: allogene.com

Peer ComparisonRevenue ($B)

▾

Loading company sections...